In an attempt to provide a unique networking facility and an opportunity to reach a highly targeted scientific audience, Select Biosciences would for the consecutive second time organise RNAi World Congress at Boston, a home to many of the world's top institutions engaged in gene silencing research. The congress, which would be held from April 30 to May 2, 2008, would feature sessions on RNAi tools, therapeutics and applications and screening, apart from the business of RNAi, microRNA tools and microRNA biology.

This three-day congress is expected to attract most influential RNAi players from America, Europe and other parts of the world. The organisers have invited experts from both academia and commerce to present timely information from current research through to commercial implementation of new technologies to make the event a big success.

The main attraction of the event would be an exhibition of selected scientific posters and service providers held concurrently with it. Also, the delegates can opt to attend the additional business tutorials, which will be running in parallel with the conference.

"To guarantee a high attendance at this exciting event we will maintain the traditional low registration fees and group booking discounts," said the organisers.